(Q46542565)

23 December 2017

title

Tumour regression after intralesional injection of interleukin 2 (IL-2) in bladder cancer. Preliminary report (English)

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340312

1 October 2023

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340312

1 October 2023

author name string

G. Pizza

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6332786

1 October 2023

G. Severini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6332786

1 October 2023

D. Menniti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6332786

1 October 2023

C. De Vinci

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6332786

1 October 2023

F. Corrado

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6332786

1 October 2023

language of work or name

English

0 references

publication date

1 September 1984

1 reference

23 December 2017

15 September 1984

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6332786

full work available at URL

1 October 2023

number of pages

9

1 reference

based on heuristic

inferred from page(s)

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fijc.2910340312

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340312

https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.2910340312

1 October 2023

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340312

International Journal of Cancer

1 October 2023

published in

1 reference

23 December 2017

volume

34

1 reference

23 December 2017

page(s)

359-367

1 reference

23 December 2017

issue

3

1 reference

23 December 2017

Clearance rates and systemic effects of intravenously administered interleukin 2 (IL-2) containing preparations in human subjects

cites work

1 reference

https://api.crossref.org/works/10.1002%2FIJC.2910340312

E rosette formation at 37 degrees C: a property of mitogen-stimulated human peripheral blood lymphocytes

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340312

Immunotherapeutic T cells?

1 October 2023

2

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340312

Continued growth of functional human T lymphocytes: production of human T-cell growth factor

1 October 2023

4

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340312

Cultured T lymphocytes against cancer: new prospects

1 October 2023

5

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340312

Interleukin-2 dependent culture of cytolytic T cell lines

1 October 2023

7

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340312

Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2

1 October 2023

8

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340312

Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells

1 October 2023

9

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340312

Protein measurement with the Folin phenol reagent

1 October 2023

11

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340312

Effect of in vitro produced transfer factor on the immune response of cancer patients

1 October 2023

12

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340312

Transitional cell carcinoma of the bladder. Differences between primary tumour and following relapses

1 October 2023

13

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340312

Suppression of T cell-mediated immunity by tumor cells: Immunogenicity versus immunosuppression and preliminary characterization of the suppressive factors

1 October 2023

16

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340312

Effect of interleukin 2 on cytotoxic effectors: I. Short-term culture of the cytotoxic effectors and the in vivo anti-tumor activity of the cultured effectors isolated from tumor site

1 October 2023

17

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340312

Specificity of auto-tumor cytotoxicity exerted by fresh, activated and propagated human T lymphocytes

1 October 2023

18

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340312

Specific cytotoxicity against autologous tumour and proliferative responses of human lymphocytes grown in interleukin 2

1 October 2023

19

1 reference

https://api.crossref.org/works/10.1002/IJC.2910340312

1 October 2023

Identifiers

1 reference

23 December 2017

1 reference

23 December 2017